Skip to main content

5354-CL-0201 A Phase 2 Randomized Open-label, Dose-ranging Study for Ureter Visualization, Using ASP5354 in Subjects Undergoing Laparoscopic/Minimally Invasive Colorectal Surgery

NCT04238481

A Phase 2 Randomized Open-label, Dose-ranging Study for Ureter Visualization, Using ASP5354 in Subjects Undergoing Laparoscopic/Minimally Invasive Colorectal Surgery

Principal Investigator

Sponsor

Astellas Pharma Global Development

The goal of this study is to find out if an investigational study drug called ASP5354 can help your study doctor visualize (see) your ureter(s) during surgery. The ureters are tubes that connect the kidney to the bladder. Usually, the body has two ureters - one for each kidney. This study will determine the most appropriate dose of ASP 5354 for ureter visualization and safety for people undergoing laparoscopic/minimally invasive colorectal surgery.